These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 4605641)

  • 1. [Effect of rifampicin on proline synthesis in the tubercule bacillus (BCG)].
    Tustanowski S; Dworak W
    Ann Acad Med Stetin; 1973; 0(8):suppl 8:105. PubMed ID: 4605641
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pathway of proline synthesis in the tubercle bacillus (BCG)].
    Tustanowski S; Dworak W
    Ann Acad Med Stetin; 1973; 0(8):suppl 8:103. PubMed ID: 4605846
    [No Abstract]   [Full Text] [Related]  

  • 3. Thin-layer chromatography of mycolic acids and its application for the characterization of BCG strains.
    Michalec C; Mára M
    J Hyg Epidemiol Microbiol Immunol; 1975; 19(4):467-70. PubMed ID: 1107419
    [No Abstract]   [Full Text] [Related]  

  • 4. Susceptibility of Mycobacterium bovis BCG vaccine strains to antituberculous antibiotics.
    Ritz N; Tebruegge M; Connell TG; Sievers A; Robins-Browne R; Curtis N
    Antimicrob Agents Chemother; 2009 Jan; 53(1):316-8. PubMed ID: 18955515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mode of action of rifampin on mycobacteria. II. Biosynthetic studies on the inhibition of ribonucleic acid polymerase of Mycobacterium bovis BCG by rifampin and uptake of rifampin- 14 C by Mycobacterium phlei.
    Konno K; Oizumi K; Oka S
    Am Rev Respir Dis; 1973 Jun; 107(6):1006-12. PubMed ID: 4576356
    [No Abstract]   [Full Text] [Related]  

  • 6. Anti-tuberculosis drug susceptibility testing of Mycobacterium bovis BCG Tokyo strain.
    Shishido Y; Mitarai S; Otomo K; Seki M; Sato A; Yano I; Koyama A; Hattori T
    Int J Tuberc Lung Dis; 2007 Dec; 11(12):1334-8. PubMed ID: 18034955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Correlation between the expression of Rv3286c, Rv2626c, Rv2031c, AND Rv3133c and the tolerance of Mycobacterium bovis BCG to rifampicin and metronidazole in different physiological conditions].
    Obozova TA; Artem'ev MI; Baranovskiĭ PM; Smetanina SE; Kiselev VI
    Probl Tuberk Bolezn Legk; 2005; (2):34-6. PubMed ID: 15881968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacodynamics of rifampicin--bacteriological and pharmacological action of rifampicin].
    Toyohara M
    Kekkaku; 1979 Dec; 54(12):576-8. PubMed ID: 392153
    [No Abstract]   [Full Text] [Related]  

  • 9. Oxidative phosphorylation in Mycobacterium tuberculosis BCG.
    Tyagi AK; Reddy TL; Venkitasubramanian TA
    Indian J Biochem Biophys; 1976 Mar; 13(1):43-5. PubMed ID: 783037
    [No Abstract]   [Full Text] [Related]  

  • 10. Sources of energy production in Mycobacterium tuberculosis BCG.
    Tyagi AK
    Indian J Chest Dis Allied Sci; 1976 Oct; 18(4):251-8. PubMed ID: 802119
    [No Abstract]   [Full Text] [Related]  

  • 11. [Differentiation between Mycobacterium tuberculosis and Mycobacterium bovis by means of Rifamycin SV susceptibility].
    Tsukamura M; Tsukamura S
    Igaku To Seibutsugaku; 1966 Jun; 72(6):350-2. PubMed ID: 4959327
    [No Abstract]   [Full Text] [Related]  

  • 12. [Morphology of colonies of the BCG Poland substrain. I. Effect of iron on the behavior of different types of BCG Poland colonies].
    Lipińska R; Rzucidlo L
    Gruzlica; 1974 Sep; 42(9):851-6. PubMed ID: 4605796
    [No Abstract]   [Full Text] [Related]  

  • 13. Recombinant Mycobacterium bovis BCG.
    Bastos RG; Borsuk S; Seixas FK; Dellagostin OA
    Vaccine; 2009 Nov; 27(47):6495-503. PubMed ID: 19720367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of the Rv2333c efflux pump (the Stp protein) from Mycobacterium tuberculosis to intrinsic antibiotic resistance in Mycobacterium bovis BCG.
    Ramón-García S; Martín C; De Rossi E; Aínsa JA
    J Antimicrob Chemother; 2007 Mar; 59(3):544-7. PubMed ID: 17242035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mode of action of kanamycin on Mycobacterium bovis, BCG (author's transl)].
    Oizumi K; Kumano N; Konno K; Oka S
    Kekkaku; 1974 Jan; 49(1):9-14. PubMed ID: 4597147
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experimental studies of the antimycobacterial activity of Rifampicine].
    Nitti V; Catena E; Ninni A; Di Filippo A
    Arch Tisiol Mal Appar Respir; 1966 Nov; 21(11):867-910. PubMed ID: 4969274
    [No Abstract]   [Full Text] [Related]  

  • 17. Characterization of the antigen 85 complex fibronectin-binding proteins derived from aged culture filtrates of Mycobacterium bovis BCG, Tice substrain.
    Oner F; Tian XX; Son K; Klegerman ME; Groves MJ
    Microbios; 1994; 78(315):69-81. PubMed ID: 8047024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth inhibition of Mycobacterium bovis, Mycobacterium tuberculosis and Mycobacterium avium in vitro: effect of 1-beta-D-2'-arabinofuranosyl and 1-(2'-deoxy-2'-fluoro-beta-D-2'-ribofuranosyl) pyrimidine nucleoside analogs.
    Johar M; Manning T; Tse C; Desroches N; Agrawal B; Kunimoto DY; Kumar R
    J Med Chem; 2007 Jul; 50(15):3696-705. PubMed ID: 17602465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early detection of rifampin in human nerve tissue after an oral dose of 600 milligrams.
    Guebre-Xabier M; Shannon EJ; Kazen R; Kebret Z; Frommel D
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1866-70. PubMed ID: 7486936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [SURVIVAL AND MULTIPLICATION OF BCG AND OF THE TUBERCLE BACILLUS IN MICE. IV. SURVIVAL AND MULTIPLICATION OF BCG DAUGHTER STRAINS AS A FUNCTION OF TIME AND DOSAGE].
    BENOIT JC; PANISSET M
    Acta Tuberc Pneumol Scand; 1963; 43():125-36. PubMed ID: 14061579
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.